DexCom Financial Ratios
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DexCom ratio analysis
DexCom earned a net margin of 17.9% in FY 2025, up from 14.3% a year earlier. Gross margin was 60.1% compared with a median of 64.7% over the prior 9 years. Return on equity reached 30.5%, meaning DexCom generated 0.30 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, DXCM traded at 31.8 times earnings; across the 7 fiscal years shown, its year-end P/E ranged from 31.8 to 253.3, with a median of 69.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
DexCom financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 31.84 | 57.09 | 95.45 | 138.10 | 253.28 | 69.50 | 49.70 | — | — | — |
| Price / sales | 5.57 | 7.91 | 13.22 | 15.15 | 21.21 | 18.11 | 3.37 | 2.48 | 1.72 | 2.18 |
| Price / book | 9.46 | 15.18 | 23.16 | 20.68 | 25.43 | 22.48 | 5.64 | 3.86 | 2.95 | 4.40 |
| Gross margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | 68.5% | 66.0% |
| Operating margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | -5.9% | -11.1% |
| Net margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | 28.5% | 6.8% | -12.3% | -7.0% | -11.4% |
| Free cash flow margin | 23.1% | 15.6% | 14.1% | 10.5% | 2.2% | 14.4% | 9.1% | 5.4% | 3.6% | 0.1% |
| Return on equity (ROE) | 30.5% | 27.4% | 26.2% | 16.0% | 10.6% | 35.4% | 11.5% | -19.2% | -12.0% | -23.1% |
| Return on assets (ROA) | 13.2% | 8.9% | 8.6% | 6.3% | 4.4% | 12.8% | 4.2% | -6.6% | -5.6% | -16.3% |
| Current ratio | 1.88 | 1.47 | 2.84 | 1.99 | 5.11 | 5.58 | 5.47 | 7.64 | 5.36 | 2.73 |
| Revenue growth | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | 30.5% | 43.1% | 43.6% | 25.3% | 42.6% |
| EPS growth | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | 20.9% | — | — | — | — |